Sensius fundamentally changes the risk-reward balance when treating cancer. Addition of Sensius’ thermotherapy to cancer treatment improves both outcome and quality of life, where mainstay treatments (radio- and chemotherapy) are inherently toxic. Sensius is a medical device company that has built a bespoke cancer therapy device using proprietary thermal technology and software. The device is designed by clinicians who use their skills and experience to craft unique thermal collars to treat initially head and neck cancer. Seventy patients have been treated with the device. A study demonstrated 81.8% of the patients having a complete response at 12 weeks following radiotherapy. The Company is now moving to build a CE marked device: already 20 interested parties are intending to purchase the device as soon as it is CE/FDA-marked. A roadmap for other cancer treatments is available.

Heathplus.ai re-uses electronic health record data to predict complications after surgery. This enables health care professionals to be more proactive in their delivery of surgical care. It reduces the impact of complications, improves outcomes and reduces cost.

Feyenally develops mobile app-based solutions that enables patients to self-examine their eyes refractive error at home using just their smartphone. Their technology uses objective testing methods.

Developer of healthcare application designed to help patients share information with doctors. The company's application interviews the patients so that they can communicate symptoms completely and accurately with the physician, enabling patients to be better prepared and helping doctors save time leading to better healthcare.

PigPug offers ADHD and autism neurofeedback therapy at home. They also provide neurofeedback brain-training games to help children overcome attention deficit disorder and increase their learning abilities.

Chiron offers a revolutionary approach to managing chronic illnesses. Based on the user's profile, it uses AI to suggest tailored self-care treatments that have the highest chance of success. It then offers a straightforward framework for evaluating the results.

Magic Horizons is building a global platform for holistic relaxation and mental health in VR, based on scientific research and a study by Humboldt-Universität zu Berlin. Magic Horizons offers a unique opportunity for relaxation and mental health in VR for every stressed out person worldwide. The result of our work at Magic Horizons are deep relaxation states at the touch of a button.

Abi Global Health is an information technology company that focuses on the hospital and healthcare industry and offers an online-based platform that connects people to doctors online to get medical advice. Its platform enables its users to get access to trusted advice from doctors, its virtual health assistant, Abi, connects people to a global network of doctors for quick answers or in-depth consultations.

Charm Economics is an economic consulting company. They provide investors with a detailed analysis of the merits of the company using detailed templates and decades of experience.

Dechra Veterinary Products is committed to help in animal care by providing quality products and the very highest level of support. The company develops and markets licensed branded pharmaceuticals for companion animals. The company specializes in the areas of dermatology, endocrinology, equine medicine and ophthalmology. It promotes and sells Vetoryl (trilostane) capsules for the treatment of canine hyperadrenocorticism; Felimazole (methimazole) coated tablets for treating feline hyperthyroidism; dermatologic ointments and creams; ophthalmic ointments; and Irap and Osteokine therapies for equine to veterinarians.

Nama Ventures is a seed stage venture capital fund focused on fueling innovation in the MENA region, particularly in Saudi Arabia. ama Ventures is built upon the fundamental idea of enabling entrepreneurs to succeed. And as founders of Nama, we are thrilled to finally have the platform to implement this idea. Our hope is that entrepreneurs willing to partner with us will see and feel our value-add approach to investing.

match.care offers digital solutions for providers of medical and nursing services to recruit qualified specialists and young talents for training. Their customers inquiries are addressed through phone, email, and online applications.

Doctor's Pharmacy provides medical equipment and pharmacy services.

Enbiosis focuses on producing scientific inventions, products, and services by using microbiome organisms. Enbiosis was founded in 2019 and was headquartered in London, United Kingdom.

Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.

Apax Partners is an independent partnership focused solely on long-term investment in growth companies.

NeoPrediX develops decision support tools with maternal, neonatal and perinatal screening platforms to evaluate, optimize and personalize medical strategies in pediatrics. We utilize intelligent algorithms and digital health solutions for neonatal and perinatal care based on deep medical data and science, developed by experienced scientists, pediatricians, and neonatologists. We transform medical data into intelligent predictions to support clinical decisions.

Developer and manufacturer of medical devices intended to manage cardiovascular health. The company offers products that provide personalized and precise management of cardiovascular risks, hypertension and peripheral artery disease (PAD) as well as screenings for vital parameters to identify risk factors that can lead to cardiovascular disease, thereby helping professionals measure what matters, prevent cardiovascular events and improve diagnosis and therapy efficiently.

Qureight is an imaging analytics company. It also aims to develop a new improved and streamlined version of its analytical platform – harnessing the ability of AI and advanced processing tools to gain new insights into respiratory diseases such as Idiopathic Pulmonary Fibrosis (IPF) and lung cancer.

Pharmacelera is a company that applies accurate Quantum-Mechanics (QM) algorithms, Machine Learning (ML) and High-Performance Computing (HPC) to mine an unexploited chemical space and propose molecular candidates that have higher chances to become a drug. The patented computational technology derives from more than 25 years of research at the University of Barcelona and it has been validated in scientific peer-reviewed publications and benchmarking studies performed by our users and customers.

Biorce is an innovating HealthAI startup committed to transforming drug development through the use of artificial intelligence.

iThera Medical offers access to innovative technology and know-how in photonic molecular imaging. The company was founded in 2010, as a spin-off from the Helmholtz Zentrum Muenchen, the German Research Center for Environmental Health (HMGU). Together, they pursue the further development of proprietary MSOT technology for use in preclinical and clinical applications.

BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company's product portfolio comprises three approved products and multiple clinical and pre-clinical product candidates. Approved products include Naglazyme® (galsulfase) for mucopolysaccharidosis VI (MPS VI), a product wholly developed and commercialized by BioMarin; Aldurazyme® (laronidase) for mucopolysaccharidosis I (MPS I), a product which BioMarin developed through a 50/50 joint venture with Genzyme Corporation; and Kuvan® (sapropterin dihydrochloride) Tablets, for phenylketonuria (PKU), developed in partnership with Merck Serono, a division of Merck KGaA of Darmstadt, Germany.

MedicubeX aims to revolutionize preventive healthcare by building a network of autonomous self-measurement and telehealth eHealth Stations. We are the most advanced health kiosk and the first one in the Nordics. The eHealth Station offers regular clinical-grade medical check-ups for everyone regardless of location.

Genexa develops medicines with cleaner inactive ingredients intended to make medicine healthier. They create organic, non-GMO medicines to treat target colds, sleep, stress relief, colds, and allergies, enabling consumers to stay fit and healthier.